Benha University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Benha Egypt (1976)

Organization Overview

First Clinical Trial
2004
NCT00366236
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ahmed Saad | Associate professor of obestetric and gynecology | Banha Faculty of Medicine, Banha Univerisity | Banha Univesity | Banha Univesity hosptals | Benha Faculty of Medecine | Benha faculty of medicine | Benha Faculty of medicine | Benha Faculty of Medicine | Benha University | Benha university faculty of medicine | Benha University, faculty of medicine | Benha university faculty of medicine , INMC | Benha University Hospital | Benha university- Qaluibya- Egypt | Department of Obstetrics and Gynecology, Benha University Hospital | Dr. Benha Faculty of Medicine | faculty of medicine benha university | Gynecology & Obstetric Department, Faculty of Medicine, Benha University | Hawaa Fertility Center | khalid abd aziz mohamed | lecturer of ob/gyn Benha faculty of medicine | Peofessor of Chest diseases, Faculty of Medicine, Benha University, Egypt. | Police Hospital

Active Ingredients

Drugs in Phase 4 Trials (5)

brolucizumab-dbll (Beovu) (2 trials)

bupivacaine (Exparel) (3 trials)

esmolol (brevibloc) (1 trial)

lifitegrast (xiidra) (1 trial)

omega-3 fatty acids (Omacor) (1 trial)

Drugs in Phase 3 Trials (32)

alprostadil (prostin) (1 trial)

cabergoline (dostinex) (3 trials)

calcium gluconate (1 trial)

carbetocin (Pabal) (1 trial)

cetrorelix (cetrotide) (1 trial)

clomifene (clomid) (2 trials)

daclatasvir (daklinza) (1 trial)

diosmetine (1 trial)

ethinyl estradiol (Estinyl) (1 trial)

follitropin alfa (Gonal-F) (1 trial)

heparin (liquaemin) (1 trial)

hydroquinone (2 trials)

isosorbide (isordil) (1 trial)

letrozole (femara) (2 trials)

lidocaine (xylocaine) (1 trial)

misoprostol (cytotec) (1 trial)

mometasone (elocon) (1 trial)

mosapride (1 trial)

nitazoxanide (Alinia) (2 trials)

norgestimate (1 trial)

onabotulinumtoxinA (Botox) (3 trials)

papaverine (1 trial)

phentolamine mesylate (regitine) (1 trial)

platelet-rich plasma (2 trials)

recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)

ribavirin (virazole) (1 trial)

simeprevir (olysio) (1 trial)

sodium chloride (2 trials)

sofosbuvir (sovaldi) (1 trial)

triamcinolone (kenalog) (4 trials)

trimix (1 trial)

triptorelin (Trelstar) (1 trial)

Drugs in Phase 2 Trials (12)

abobotulinumtoxinA (Dysport) (1 trial)

acetaminophen (tylenol) (2 trials)

chromax (1 trial)

dexamethasone (3 trials)

dexmedetomidine (precedex) (3 trials)

dydrgesterone (1 trial)

enoxaparin (lovenox) (1 trial)

montelukast (singulair) (1 trial)

oxytocin (syntocinon) (1 trial)

prednisolone (hydeltra) (1 trial)

silodosin (rapaflo) (1 trial)

tranexamic acid (cyklokapron) (2 trials)

Drugs in Phase 1 Trials (8)

Cyproterone (Androcur) (1 trial)

finasteride (Proscar) (1 trial)

insulin human (humulin) (1 trial)

methylprednisolone (medrol) (1 trial)

pentoxifylline (trental) (1 trial)

saccharomyces cerevisiae (1 trial)

vitamin c (1 trial)

vitamin e (2 trials)

Drugs in Other Trials (16)

aflibercept (zaltrap) (1 trial)

alpha-lipoic acid (1 trial)

desmopressin (ddavp) (1 trial)

febuxostat (uloric) (1 trial)

fentanyl (Innovar) (2 trials)

hepatitis b vaccine (recombinant) (Recombivax) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

ivermectin (stromectol) (1 trial)

levobupivacaine (chirocaine) (1 trial)

magnesium (1 trial)

midazolam (versed) (2 trials)

midodrine (proamatine) (1 trial)

mirabegron (myrbetriq) (1 trial)

nalbuphine (nubain) (1 trial)

sildenafil (viagra) (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abortion, Habitual (Phase 3)

Abortion, Spontaneous (Phase 3)

Amebiasis (Phase 3)

Anovulation (Phase 3)

Bursitis (Phase 1)

Cysts (Phase 3)

Dysentery, Amebic (Phase 3)

Eclampsia (Phase 3)

Erectile Dysfunction (Phase 3)

Fetal Death (Phase 3)

Hyperplasia (Phase 2)

Ileus (Phase 3)

Infertility (Phase 3)

Infertility, Female (Phase 3)

Infertility, Male (Phase 1)

Olfaction Disorders (Phase 3)

Oligohydramnios (Phase 3)

Ovarian Cysts (Phase 3)

Ovarian Hyperstimulation Syndrome (Phase 3)

Polycystic Ovary Syndrome (Phase 3)

Pre-Eclampsia (Phase 3)

Prostatic Hyperplasia (Phase 2)

Retinal Dystrophies (Phase 4)

Shoulder Pain (Phase 1)

Sinusitis (Phase 3)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 61
  • # of Trial APIs: 73